A Phase II Study of Docetaxel for the Treatment of Recurrent Osteosarcoma

Authors
Publication date
1 January 2004
Publisher
Hindawi Publishing Corporation
Doi
    View on PubMed

    Abstract

    Purpose: To determine the response and toxicity of docetaxel in recurrent osteosarcoma and related spindle cell tumours of bone

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Directory of Open Access Journals

      redirect
      oaioai:doaj.org/article:631dcc359...
      Last time updated on 18/12/2014